Skip to main content
Figure 4 | BMC Infectious Diseases

Figure 4

From: Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands

Figure 4

Cost-effectiveness and price differential of HPV vaccines in setting with a reduced screening compliance. Left panel shows cost-effectiveness of HPV vaccination. Black: € per life-year gained; red: € per quality-adjusted life years gained. Circles: quadrivalent vaccine; squares: bivalent vaccine. Right panel: price differential between bivalent and quadrivalent HPV vaccine. Blue squares: price differential considering the life-years gained; red dots: idem if quality-adjusted life years gained are considered.

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us